You can buy or sell INNT and other stocks, options, ETFs, and crypto commission-free!
Innovate Biopharmaceuticals, Inc. Common Stock, also called Innovate Biopharmaceuticals, is a clinical-stage biopharmaceutical company. Read More It foucs on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.
Raleigh, North Carolina
52 Week High
52 Week Low
Yahoo FinanceMay 9
Innovate Biopharma Announces Analyst Event on Monday, May 20, 2019, in San Diego
RALEIGH, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (INNT), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory disease, announced that it plans to host an Analyst Event on Monday, May 20, 2019, in San Diego, CA. The event is intended to provide clinical and operational progress updates, including details regarding the company’s Phase 3 celiac disease clinical trial. Event: Innovate Analyst Event Date: Monday,...
Yahoo FinanceMay 1
Innovate Biopharmaceuticals Announces Closing of $8.7 Million Registered Direct Offering
RALEIGH, N.C., May 01, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (INNT) today announced the closing of its previously announced registered direct offering of 4,318,272 shares of common stock at a purchase price of $2.025 per share, for aggregate gross proceeds of approximately $8.7 million. Innovate also issued unregistered warrants to purchase up to 4,318,272 shares of common stock with an exercise price of $2.13 per share. The warrants are exercisable immediately following the issuance an...
Yahoo FinanceApr 30
Edited Transcript of INNT earnings conference call or presentation 29-Apr-19 12:00pm GMT
Q1 2019 Innovate Biopharmaceuticals Inc Earnings Call SIMI VALLEY May 1, 2019 (Thomson StreetEvents) -- Edited Transcript of Innovate Biopharmaceuticals Inc earnings conference call or presentation Monday, April 29, 2019 at 12:00:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Jennifer K. Zimmons Strategic Growth International, ...
Expected Aug 9, Pre-Market